SCHEMBL21362625

SCHEMBL21362625

CCCc1nn(C)c(=O)cc1C(C)N1C(=O)c2ccccc2C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.38
TSHR P16473 1/20 0.38
PDE5A O76074 6/20 0.38
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
HPGD P15428 1/20 0.38
PDE1A P54750 1/20 0.38
PDE1B Q01064 1/20 0.38
KMT2A Q03164 1/20 0.38
PDE1C Q14123 1/20 0.38
TDP1 Q9NUW8 1/20 0.37
LMNA P02545 2/20 0.36
NPC1 O15118 3/20 0.35
TP53 P04637 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PDE3B Q13370 2/20 0.34
PDE3A Q14432 2/20 0.34
SMN1; SMN2 Q16637 2/20 0.34
RECQL P46063 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21362091 0.79 USP2 (0.41) USP2TSHRALDH1A1KMT2ATDP1
SCHEMBL252646 0.74 TDP1 (0.34) PDE5AALDH1A1MEN1HPGDPDE1A
SCHEMBL252645 0.74 TDP1 (0.34) PDE5AALDH1A1MEN1HPGDPDE1A
SCHEMBL21953526 0.68 NR1H2 (0.50) ALDH1A1KMT2ATDP1LMNA
SCHEMBL252602 0.68 MAPT (0.35) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL252601 0.68 MAPT (0.35) ALDH1A1MEN1KMT2ATDP1LMNA
SCHEMBL20752343 0.67 DNMT1 (0.42) ALDH1A1TDP1LMNANPC1RAB9A
SCHEMBL252244 0.65 PDE4A (0.39) USP2TSHRALDH1A1HPGDTDP1
SCHEMBL2896546 0.65 LMNA (0.41) USP2TSHRALDH1A1HPGDKMT2A
SCHEMBL14872903 0.64 USP2 (0.43) USP2TSHRALDH1A1MEN1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3539960-A1 NITROGENOUS MACROCYCLIC COMPOUND, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION AND APPLICATION THEREOF Luoxin Pharmaceutical (Shanghai) Co., Ltd. (CN) 2019-09-18 EP disclosed